ABEO 8.060 € (+1,51 %)
SAFRAN 282.400 € (-6,80 %)
HOPIUM 0.008 € (-2,44 %)
BE SEMICONDUCTOR 227.900 € (+0,40 %)
GENFIT 8.900 € (-2,41 %)
SHELL PLC 37.695 € (+0,24 %)
STMICROELECTRONICS 37.610 € (+0,90 %)
EXOR NV 70.000 € (-0,28 %)
SANOFI 81.020 € (-1,23 %)
LVMH 486.000 € (-0,93 %)
UMG 20.080 € (-1,47 %)
KERING 243.200 € (-2,01 %)
MR BRICOLAGE 4.670 € (-1,68 %)
CARREFOUR 16.710 € (-0,54 %)
AIRBUS 170.520 € (-1,54 %)
AXA 42.420 € (-0,07 %)
FLEURY MICHON 22.300 € (0,00 %)
AALBERTS NV 31.440 € (-0,69 %)
FASTNED 29.800 € (+5,11 %)
TIKEHAU CAPITAL 19.200 € (-2,34 %)
JCDECAUX 19.230 € (-3,42 %)
ATOS 36.240 € (-2,74 %)
NANOBIOTIX 26.340 € (-5,05 %)
SARTORIUS STED BIO 188.500 € (+0,96 %)
LEGRAND 147.750 € (-0,54 %)
SOITEC 100.750 € (+0,75 %)
ARKEMA 61.600 € (-0,65 %)
CSG 21.040 € (-0,82 %)
ACCOR 44.340 € (-2,27 %)
UNIBAIL-RODAMCO-WE 104.750 € (-0,62 %)
AIR FRANCE -KLM 9.896 € (-3,50 %)
BIOMERIEUX 90.600 € (+0,50 %)
ADOCIA 5.720 € (+16,83 %)
ABN AMRO BANK N.V. 30.200 € (+0,33 %)
MANITOU BF 21.750 € (+1,64 %)
BOLLORE 5.080 € (+1,09 %)
CRCAM ILLE-VIL.CCI 116.120 € (+0,66 %)
CTP 16.100 € (-1,35 %)
GROUPE OKWIND 1.200 € (+36,36 %)
BENETEAU 7.100 € (-1,11 %)
ABIVAX 98.000 € (-2,58 %)
BNP PARIBAS ACT.A 92.140 € (-0,50 %)
BASIC-FIT 31.460 € (-0,57 %)
CIECHARGEURSINVEST 8.500 € (0,00 %)
THALES 247.700 € (-5,92 %)
Coca-ColaEuropacif 82.100 € (-1,20 %)
SPIE 46.460 € (-1,27 %)
TECHNIP ENERGIES 39.420 € (-0,15 %)
SCHNEIDER ELECTRIC 272.100 € (-0,55 %)
ING GROEP N.V. 24.495 € (0,00 %)
ALSTOM 17.050 € (-0,20 %)
GECINA 72.400 € (-0,21 %)
EDENRED 20.620 € (+1,53 %)
BOUYGUES 52.200 € (-0,53 %)
UNILEVER 48.705 € (-1,23 %)
REXEL 36.750 € (-1,63 %)
VALEO 11.120 € (-1,20 %)
AKZO NOBEL 52.200 € (-2,06 %)
EURONEXT 146.600 € (-0,07 %)
ELIS 26.580 € (-0,97 %) |
20/04/2026 14:30
TripSitter Announces Discovery NoticeVANCOUVER, BC / ACCESS Newswire / April 20, 2026 / TripSitter Clinic Ltd. (the "Company" or "TripSitter") (CSE:KETA) announces that it has been identified by the plaintiffs as a respondent in discovery in connection with a negligence and wrongful death lawsuit filed in the State of Illinois. The Company has not been named as a defendant in the lawsuit, and the action does not include any claims or allegations of wrongdoing against TripSitter. The Company is seeking legal advice regarding its obligations as a respondent in discovery and will provide further updates when appropriate. For more information, please contact: TripSitter Clinic Ltd. The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and does not accept responsibility for the adequacy or accuracy of this release. CAUTIONARY DISCLAIMER STATEMENT This news release may include certain "forward-looking statements" under applicable Canadian securities legislation, including with respect to the business objectives of the Company. Forward-looking statements are necessarily based upon several estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties, and uncertain capital markets. Readers are cautioned that actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. SOURCE: TripSitter Clinic Ltd. View the original press release on ACCESS Newswire Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière